Liz Fandel, chief marketing and innovation officer of FellowshipLIFE, shares thoughts about the changing expectations of senior living residents and prospective residents, ways that providers are ...
(HealthDay News) — The US Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary ...